ArticleTranslational cancer research2026

Telmisartan enhances anti-PD-1 efficacy in MSS colorectal cancer via modulation of PD-L1 and STAT3 signaling.

Xin Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.